Fibertex Nonwovens increasing capacity in Czech Republic, Turkey
May 04, 2021 - Denmark
Fibertex Nonwovens, headquartered in Aalborg, is making investments to increase capacity in its existing plants in the Czech Republic and Turkey. This marks the second stage of expansions. The investments have been prompted by increased global demand for the company’s high-tech and sustainable speciality products. Earlier, it had announced plans for the US.
The company is investing DKK 300 million in its plants in the Czech Republic and Turkey. In March 2021, Fibertex Nonwovens, a subsidiary of the Danish industrial conglomerate Schouw & Co in Aarhus, Denmark, announced an investment of just over DKK 300 million in a capacity expansion of one of the company’s two plants in the US. Fibertex Nonwovens is now investing the same amount in Europe with a capacity expansion of the company’s existing plants in the Czech Republic and Turkey.
“Demand for our nonwovens has increased significantly in recent years. It concerns particularly the more specialised applications and high-performance materials for the healthcare sector, industrial products, specialist acoustic products for the automotive industry, nanofiltration for industrial purposes, etc. Our business development and research activities over the past ten years have afforded us a leading position in both Europe and the US, and this is the direct reason for the total investment of just over DKK 600 million in capacity expansions,” explains Jørgen Bech Madsen, CEO of Fibertex Nonwovens, from the company’s headquarters in Aalborg.
He adds that the coronavirus pandemic has led to an explosive demand for hygiene products, such as disinfectant wipes. Fibertex Nonwovens ability to produce specialised products with unique properties at relatively low costs is increasingly recognised in the market.
Fibertex Nonwovens is increasingly using the spunlace technology which is a relatively new production method where high-speed jets of water are used to entangle the fibres of the nonwoven textiles. Fibertex Nonwovens has years of positive experience with this technology, and the major share of the investment will be spent on a new spunlace production line at the company’s plant in Svitavy in the eastern Czech Republic.
“We’ve got a lean and high-tech production setup with clear focus on innovation, and the new production line is to serve the huge demand for disinfection wipes from the healthcare sector. This demand was rising even before the coronavirus pandemic, but we expect it to increase even further in the coming years. With this new investment, we’ll be able to offer new and sustainable product properties that’ll help meet the demands of the future in this field. At the same time, we’re freeing up capacity at several of our other European plants, allowing us to explore new opportunities within the manufacture of acoustic products for the automotive industry and products for filtration,” Bech Madsen continues.
In 2015, Fibertex Nonwovens acquired the nonwovens operations of the Turkish manufacturer Ribatek. The plant is located in the city of Cerkezkoy in western Turkey, nearly 100 kilometres northwest of Istanbul, and it specialises in spunlacing. Here, Fibertex Nonwovens is now investing in an expansion of the current production facilities as well as adding additional lines in finishing and coating with a view to manufacturing specialised nonwovens products.
“The plant in Turkey complements the production units of our other European and US plants by manufacturing high-tech products. For example, we’re experiencing growing demand for various forms of finishing, which allow us to add entirely unique properties to the products,” says Bech Madsen.
The investments in Europe and the US totalling DKK 600 million form part of an ambitious growth strategy for the period to 2026.
“It’s crucial that we take advantage of the current momentum to strengthen our position. There’s an ‘open window’ for expansion and we’ve got the resources to take advantage of the opportunities,” says Jens Bjerg Sørensen, president and CEO of Schouw & Co. He continues: “Fibertex Nonwovens has huge potential and with the new investments in both the US and Europe, it can significantly increase its revenue and earnings. It’s simply an excellent business case.”
The company is investing DKK 300 million in its plants in the Czech Republic and Turkey. In March 2021, Fibertex Nonwovens, a subsidiary of the Danish industrial conglomerate Schouw & Co in Aarhus, Denmark, announced an investment of just over DKK 300 million in a capacity expansion of one of the company’s two plants in the US. Fibertex Nonwovens is now investing the same amount in Europe with a capacity expansion of the company’s existing plants in the Czech Republic and Turkey.
“Demand for our nonwovens has increased significantly in recent years. It concerns particularly the more specialised applications and high-performance materials for the healthcare sector, industrial products, specialist acoustic products for the automotive industry, nanofiltration for industrial purposes, etc. Our business development and research activities over the past ten years have afforded us a leading position in both Europe and the US, and this is the direct reason for the total investment of just over DKK 600 million in capacity expansions,” explains Jørgen Bech Madsen, CEO of Fibertex Nonwovens, from the company’s headquarters in Aalborg.
He adds that the coronavirus pandemic has led to an explosive demand for hygiene products, such as disinfectant wipes. Fibertex Nonwovens ability to produce specialised products with unique properties at relatively low costs is increasingly recognised in the market.
Fibertex Nonwovens is increasingly using the spunlace technology which is a relatively new production method where high-speed jets of water are used to entangle the fibres of the nonwoven textiles. Fibertex Nonwovens has years of positive experience with this technology, and the major share of the investment will be spent on a new spunlace production line at the company’s plant in Svitavy in the eastern Czech Republic.
“We’ve got a lean and high-tech production setup with clear focus on innovation, and the new production line is to serve the huge demand for disinfection wipes from the healthcare sector. This demand was rising even before the coronavirus pandemic, but we expect it to increase even further in the coming years. With this new investment, we’ll be able to offer new and sustainable product properties that’ll help meet the demands of the future in this field. At the same time, we’re freeing up capacity at several of our other European plants, allowing us to explore new opportunities within the manufacture of acoustic products for the automotive industry and products for filtration,” Bech Madsen continues.
In 2015, Fibertex Nonwovens acquired the nonwovens operations of the Turkish manufacturer Ribatek. The plant is located in the city of Cerkezkoy in western Turkey, nearly 100 kilometres northwest of Istanbul, and it specialises in spunlacing. Here, Fibertex Nonwovens is now investing in an expansion of the current production facilities as well as adding additional lines in finishing and coating with a view to manufacturing specialised nonwovens products.
“The plant in Turkey complements the production units of our other European and US plants by manufacturing high-tech products. For example, we’re experiencing growing demand for various forms of finishing, which allow us to add entirely unique properties to the products,” says Bech Madsen.
The investments in Europe and the US totalling DKK 600 million form part of an ambitious growth strategy for the period to 2026.
“It’s crucial that we take advantage of the current momentum to strengthen our position. There’s an ‘open window’ for expansion and we’ve got the resources to take advantage of the opportunities,” says Jens Bjerg Sørensen, president and CEO of Schouw & Co. He continues: “Fibertex Nonwovens has huge potential and with the new investments in both the US and Europe, it can significantly increase its revenue and earnings. It’s simply an excellent business case.”